Serum levels of GM-CSF 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study

International Immunopharmacology

Volumn 9, Issue 13-14, 2009, Pages 1499-1503

  Amiri, Sara ^a   Ghazanfari, Tooba ^a   Yaraee, Roya ^a   Salimi, Hassan ^a   Ebtekar, Massoumeh ^b   Shams, Jalaleddin ^a   Ghasemi, Hassan ^a   Pourfarzam, Shahryar ^a   Moin, Athar ^a   Sharifnia, Zarin ^a   Soroush, Mohammad R ^c   Faghihzadeh, Soghrat ^b   Hassan, Zuhair M ^b  

^a SHAHED UNIVERSITY   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c JANBAZAN MEDICAL AND ENGINEERING RESEARCH CENTER JMERC   (Iran)

Author keywords

Cytokines; GM CSF; Hematopoietic; Inflammatory marker; Iran; Mustard gas

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MUSTARD GAS; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BASOPHIL; BLOOD CELL COUNT; CONTROLLED STUDY; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; EOSINOPHIL COUNT; EYE TOXICITY; HUMAN; INFLAMMATION; IRAN; LUNG TOXICITY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN TOXICITY;

CHEMICAL WARFARE AGENTS; COHORT STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IRAN; LUNG DISEASES; MUSTARD GAS; TIME FACTORS;

EID: 70350573538     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.08.023     Document Type: Article

References (34)

1. Hamilton J.A., and Anderson G.P. GM-CSF biology. Growth Factors 22 (2004) 225-231
2. Chang D.Z., Lomazow W., Joy S.C., Stan R., and Perales M.A. Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines. Hematology 9 3 (2004) 207-215
3. Fleetwood A.J., Cook A.D., and Hamilton J.A. Functions of granulocyte-macrophage colony-stimulating factor. Crit Rev Immunol 25 5 (2005) 405-428
4. Sabourin C.L.K., Petrali J.P., and Casillas R.P. Alterations in inflammatory cytokine gene expression in sulfur mustard-exposed mouse skin. J Biochem Mol Toxic 14 6 (2000) 291-302
5. Hassan Z.M., and Ebtekar M. Immunological consequence of sulfur mustard exposure. Immunol Lett 83 3 (2002 Oct 1) 151-152
6. Khateri S., Ghanei M., Keshavarz S., Soroush M., and Haines D. Incidence of lung, eye, and skin lesions as late complications in 34, 000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45 11 (2003 Nov) 1136-1143
7. Moaiedmohseni S., Ghazanfari T., Araghizadeh H., Soroush M.R., Yaraee R., Hassan Z.M., et al. Long-term health status 20 years after sulfur mustard exposure. Toxin Rev 28 1 (2009) 3-7
8. Shams J., Ghazanfari T., Yaraee R., Vaez Mahdavi M.R., Soroush M.R., Hassan Z.M., et al. Long-term hematological consequences of sulfur mustard on civilians of Sardasht 20 years after exposure. Toxin Rev 28 1 (2009) 39-43
9. Jalali Nadoushan M.R., Ghazanfari T., Yaraee R., Vaez Mahdavi M.R., Soroush M.R., Moaiedmohseni S., et al. Total serum bilirubinemia and intensity of sulfur mustard exposure in Iranian chemical victims 20 years after exposure. Toxin Rev 28 1 (2009) 44-47
10. Yaraee R., Ghazanfari T., Ebtekar M., Ardestani SK., Rezaei A., Kariminia A., et al. Alterations in serum levels of inflammatory cytokines (TNF, IL-1alpha, IL-1beta and IL-1Ra) 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immuno 9 (2009) 1466-1470 (this issue)
11. Poufarzam S., Ghazanfari T., Yaraee R., Ghasemi H., Hassan ZM., Faghihzadeh S., et al. Serum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immuno 9 (2009) 1482-1488 (this issue)
12. Ghazanfari T., Faghihzadeh S., Araghizadeh H., Soroush M.R., Yaraee R., Hassan Z.M., et al. Sardasht-Iran Cohort Study of chemical warfare victims: design and methods. Arch Iran Med 12 1 (2009) 5-14
13. American Thoracic Society. Standardization of spirometry. Am J Respir Crit Care Med 152 (1995) 1107-1136
14. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
15. Pourfarzam Sh., Ghazanfari T., Merasizadeh J., Ghanei M., Azimi G., Araghizadeh H., et al. Long-term pulmonary complications in sulfur mustard victims of Sardasht, Iran. Toxin Rev 28 1 (2009) 8-13
16. Moin A., Ghazanfari T., Davoudi S.M., Emadi N., Panahi Y., Hassan Z.M., et al. Long-term skin findings of sulfur mustard exposure on the civilians of Sardasht, Iran. Toxin Rev 28 1 (2009) 24-29
17. Ghasemi H., Ghazanfari T., Babaei M., Soroush M., Yaraee R., Ghassemi-Broumand M., et al. Long-term ocular complications of sulfur mustard in the civilian victims of Sardasht, Iran. Cutan Ocul Toxicol 27 4 (2008) 317-326
18. Duan R., Remeijer L., van Dun J.M., Osterhaus A.D., and Verjans G.M. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK. Invest Ophthalmol Vis Sci 48 1 (2007) 277-284
19. Ghanei M., and Harandi A.A. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol 19 5 (2007) 451-456
20. Emad A., and Emad Y. Relationship between airway reactivity induced by methacholine or ultrasonically nebulized distilled cold water and BAL fluid cellular constituents in patients with sulfur mustard gas-induced asthma. J Aerosol Med 20 3 (2007) 342-351
21. Mahmoudi M., Hefazi M., Rastin M., and Balali-Mood M. Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans. Int Immunopharmacol 5 9 (2005) 1479-1485
22. Emad A., and Emad Y. Increased granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) levels in BAL fluid from patients with sulfur mustard gas-induced pulmonary fibrosis. J Aerosol Med 20 3 (2007) 352-360
23. Nakamura Y., Ozaki T., Kamei T., Kawaji K., Banno K., Miki S., et al. Factors that stimulate the proliferation and survival of eosinophils in eosinophilic pleural effusion: relationship to granulocytelmacrophage colony-stimulating factor, interleukin-5, interleukin-3. Am J Respir Cell Mol Biol 8 (1993) 605-611
24. Barnes P.J., Shapiro S.D., and Pauwels R.A. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22 (2003) 672-688
25. Balbi B., Bason C., Balleari E., Fiasella F., Pesci A., Ghio R., et al. Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis. Eur Respir J 10 (1997) 846-850
26. Mrugacz M., Zywalewska N., and Bakunowicz-Lazarczyk A. Immunological aspects of tear fluid. Klin Oczna 107 (2005) 551-554
27. Hingorani M., Calder V., Jolly G., Buckley R.J., and Lightman S.L. Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases. J Allergy Clin Immunol 102 5 (1998) 821-830
28. Thakur A., and Willcox M.D. Cytokine and lipid inflammatory mediator profile of human tears during contact lens associated inflammatory diseases. Exp Eye Res 67 1 (1998 Jul) 9-19
29. Wakefield D., and Lloyd A. The role of cytokines in the pathogenesis of inflammatory eye disease. Cytokine 4 1 (1992) 1-5
30. Ghanei M., and Harandi A.A. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol 19 5 (2007) 451-456
31. Emadi S.N., Hosseini-Khalili A., Soroush M.R., Davoodi S.M., and Aghamiri S.S. Mustard gas scarring with specific pigmentary, trophic and vascular characteristics (case report, 16-year post-exposure). Ecotoxicol Environ Saf 69 3 (2008) 574-576
32. Richardson S., and Gelfand J. Immunobiologicals, cytokines, and growth factors in dermatology. In: GLKSGBPALD W. (Ed). Fitzpatrick's dermatology in general medicine. 7th ed. (2008), McGraw-Hill, New York
33. Pastore S., Fanales-Belasio E., Albanesi C., Chinni L.M., and Giannetti A. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. J Clin Invest 99 12 (1997) 3009-3017
34. Bratton D.L., Hamid Q., Boguniewicz M., Doherty D.E., Kailey J.M., and Leung D.Y.M. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J Clin Invest 95 (1995) 211-218